|
1
|
Nakou ES, Liberopoulos EN, Milionis HJ and
Elisaf MS: The role of C-reactive protein in atherosclerotic
cardiovascular disease: An overview. Curr Vasc Pharmacol.
6:258–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bansal T, Pandey A, Deepa D and Asthana
AK: C-reactive proten (CRP) and its association with periodontal
disease: A brief review. J Clin Diagn Res. 8:ZE21–ZE24.
2014.PubMed/NCBI
|
|
3
|
Kones R: Rosuvastatin, inflammation,
C-reactive protein, JUPITER, and primary prevention of
cardiovascular disease-a perspective. Drug Des Devel Ther.
4:383–413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeh ET and Willerson JT: Coming of age of
C-reactive protein: Using inflammation markers in cardiology.
Circulation. 107:370–371. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Q, Kang T, Tian X, Ma Y, Li M, Richards
J, Bythwood T, Wang Y, Li X, Liu D, et al: Multimeric stability of
human C-reactive protein in archived specimens. PLoS One.
8:e580942013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kilpatrick JM and Volanakis JE: Molecular
genetics, structure, and function of C-reactive protein. Immunol
Res. 10:43–53. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bodman-Smith KB, Melendez AJ, Campbell I,
Harrison PT, Allen JM and Raynes JG: C-reactive protein-mediated
phagocytosis and phospholipase D signalling through the
high-affinity receptor for immunoglobulin G (FcgammaRI).
Immunology. 107:252–260. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Okemefuna AI, Nan R, Miller A, Gor J and
Perkins SJ: Complement factor H binds at two independent sites to
C-reactive protein in acute phase concentrations. J Biol Chem.
285:1053–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peisajovich A, Marnell L, Mold C and Du
Clos TW: C-reactive protein at the interface between innate
immunity and inflammation. Expert Rev Clin Immunol. 4:379–390.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Diehl EE, Haines GK III, Radosevich JA and
Potempa LA: Immunohistochemical localization of modified C-reactive
protein antigen in normal vascular tissue. Am J Med Sci. 319:79–83.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Molins B, Peña E, Vilahur G, Mendieta C,
Slevin M and Badimon L: C-reactive protein isoforms differ in their
effects on thrombus growth. Arterioscler Thromb Vasc Biol.
28:2239–2246. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisenhardt SU, Habersberger J, Murphy A,
Chen YC, Woollard KJ, Bassler N, Qian H, von Zur Muhlen C,
Hagemeyer CE, Ahrens I, et al: Dissociation of pentameric to
monomeric C-reactive protein on activated platelets localizes
inflammation to atherosclerotic plaques. Circ Res. 105:128–137.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji SR, Ma L, Bai CJ, Shi JM, Li HY,
Potempa LA, Filep JG, Zhao J and Wu Y: Monomeric C-reactive protein
activates endothelial cells via interaction with lipid raft
microdomains. FASEB J. 23:1806–1816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mihlan M, Blom AM, Kupreishvili K, Lauer
N, Stelzner K, Bergström F, Niessen HW and Zipfel PF: Monomeric
C-reactive protein modulates classic complement activation on
necrotic cells. FASEB J. 25:4198–4210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khreiss T, József L, Potempa LA and Filep
JG: Opposing effects of C-reactive protein isoforms on
shear-induced neutrophil-platelet adhesion and neutrophil
aggregation in whole blood. Circulation. 110:2713–2720. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khreiss T, József L, Potempa LA and Filep
JG: Conformational rearrangement in C-reactive protein is required
for proinflammatory actions on human endothelial cells.
Circulation. 109:2016–2022. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Potempa LA, Zeller JM, Fiedel BA,
Kinoshita CM and Gewurz H: Stimulation of human neutrophils,
monocytes, and platelets by modified C-reactive protein (CRP)
expressing a neoantigenic specificity. Inflammation. 12:391–405.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schwedler SB, Amann K, Wernicke K, Krebs
A, Nauck M, Wanner C, Potempa LA and Galle J: Native C-reactive
protein increases whereas modified C-reactive protein reduces
atherosclerosis in apolipoprotein E-knockout mice. Circulation.
112:1016–1023. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Q, Ma Y, Li W, Xu W, Ma L, Fu G, Tian
X, Wang Y, Li X, Bythwood T, et al: A promoter that drives gene
expression preferentially in male transgenic rats. Transgenic Res.
23:341–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Xu W, Cui Y, Ma L, Richards J, Li W,
Ma Y, Fu G, Bythwood T, Wang Y, et al: A prelimininary exploration
on DNA methylation of transgene across generations in transgenic
rats. Sci Rep. 5:82922015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baltz ML, de Beer FC, Feinstein A, Munn
EA, Milstein CP, Fletcher TC, March JF, Taylor J, Bruton C, Clamp
JR, et al: Phylogenetic aspects of C-reactive protein and related
proteins. Ann N Y Acad Sci. 389:49–75. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hammond DJ Jr, Singh SK, Thompson JA,
Beeler BW, Rusiñol AE, Pangburn MK, Potempa LA and Agrawal A:
Identification of acidic pH-dependent ligands of pentameric
C-reactive protein. J Biol Chem. 285:36235–36244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang MY, Ji SR, Bai CJ, El Kebir D, Li HY,
Shi JM, Zhu W, Costantino S, Zhou HH, Potempa LA, et al: A redox
switch in C-reactive protein modulates activation of endothelial
cells. FASEB J. 25:3186–3196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khreiss T, József L, Potempa LA and Filep
JG: Loss of pentameric symmetry in C-reactive protein induces
interleukin-8 secretion through peroxynitrite signaling in human
neutrophils. Circ Res. 97:690–697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zouki C, Haas B, Chan JS, Potempa LA and
Filep JG: Loss of pentameric symmetry of C-reactive protein is
associated with promotion of neutrophil-endothelial cell adhesion.
J Immunol. 167:5355–5361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Motie M, Brockmeier S and Potempa LA:
Binding of model soluble immune complexes to modified C-reactive
protein. J Immunol. 156:4435–4441. 1996.PubMed/NCBI
|
|
27
|
Wu Y, Ji SR, Wang HW and Sui SF: Study of
the spontaneous dissociation of rabbit C-reactive protein.
Biochemistry (Mosc). 67:1377–1382. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji SR, Wu Y, Zhu L, Potempa LA, Sheng FL,
Lu W and Zhao J: Cell membranes and liposomes dissociate C-reactive
protein (CRP) to form a new, biologically active structural
intermediate: mCRP(m). FASEB J. 21:284–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kresl JJ, Potempa LA and Anderson BE:
Conversion of native oligomeric to a modified monomeric form of
human C-reactive protein. Int J Biochem Cell Biol. 30:1415–1426.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okemefuna AI, Stach L, Rana S, Buetas AJ,
Gor J and Perkins SJ: C-reactive protein exists in an NaCl
concentration-dependent pentamer-decamer equilibrium in
physiological buffer. J Biol Chem. 285:1041–1052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khreiss T, József L, Hossain S, Chan JS,
Potempa LA and Filep JG: Loss of pentameric symmetry of C-reactive
protein is associated with delayed apoptosis of human neutrophils.
J Biol Chem. 277:40775–40781. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao J and Shi XH: Study of the
interaction of the C-reactive protein monomer with the U937
monocyte. Cell Mol Biol Lett. 15:485–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Asztalos BF, Horan MS, Horvath KV,
McDermott AY, Chalasani NP and Schaefer EJ: Obesity associated
molecular forms of C-reactive protein in human. PLoS One.
9:e1092382014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beri A, Contractor T, Khasnis A and Thakur
R: Statins and the reduction of sudden cardiac death:
Antiarrhythmic or anti-ischemic effect? Am J Cardiovasc Drugs.
10:155–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Juma WM, Lira A, Marzuk A, Marzuk Z, Hakim
AM and Thompson CS: C-reactive protein expression in a rodent model
of chronic cerebral hypoperfusion. Brain Res. 1414:85–93. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peyrin-Biroulet L, Gonzalez F, Dubuquoy L,
Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M,
Béclin E, Odou MF, et al: Mesenteric fat as a source of C reactive
protein and as a target for bacterial translocation in Crohn's
disease. Gut. 61:78–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang MY, Zhou HH, Zhang SC, Hui F, Zhu W,
Su HX, Guo HY, Li XW, Ji SR and Wu Y: Recurrent mutations at
C-reactive protein gene promoter SNP position −286 in human
cancers. Cell Res. 24:505–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
